This act will have an effect on physicians and patients. Experience the testimony and learn the impact of this regulation from the Energy & Committee hearing .
The bill eliminates the requirement for compounding pharmacies to register with the FDA as drug manufacturers. Track the progress of this bill through the House of Representatives.
The International Academy of Compounding Pharmacists (IACP) testified before the U.S. House of Representatives' Energy & Commerce's Health Subcommittee Hearing on pharmacy compounding, " Examining Implementation of the Compounding Quality Act ."
